Search

Your search keyword '"Stuart Keller"' showing total 16 results
Start Over Author "Stuart Keller" Journal journal of the american college of cardiology
16 results on '"Stuart Keller"'

1. TCT-747 Associations between Stent Diameter and Clinical Outcomes in ACS PCI Using Second Generation Drug-Eluting Stents: From the PROMETHEUS Study

Author

Roxana Mehran, Serdar Farhan, Madhav Sharma, Joseph B. Muhlestein, Annapoorna Kini, Sunil V. Rao, Craig Strauss, William S. Weintraub, Stuart Keller, Samantha Sartori, Zhen Ge, Stuart J. Pocock, Brian A. Baker, Sandra Weiss, Catalin Toma, Usman Baber, Samir R. Kapadia, Mark B. Effron, Timothy D. Henry, Anthony C. DeFranco, Jaya Chandrasekhar, and Abdul Qadeer

Subjects
Drug, medicine.medical_specialty, business.industry, media_common.quotation_subject, medicine.medical_treatment, Conventional PCI, medicine, Stent, Radiology, Cardiology and Cardiovascular Medicine, business, media_common, Surgery
Published
2017
Full Text
View/download PDF

2. TCT-220 Effect of prasugrel versus clopidogrel in ACS patients with high or low BMI undergoing PCI: Results from the PROMETHEUS Study

Author

Usman Baber, Brian A. Baker, William S. Weintraub, Stuart Keller, Annapoorna Kini, Kanhaiya L. Poddar, Jennifer Chao, Samir R. Kapadia, Mark B. Effron, Roxana Mehran, Sunil V. Rao, Craig Strauss, Sandra Weiss, Timothy D. Henry, Melissa Aquino, Anthony C. DeFranco, Samantha Sartori, Jaya Chandrasekhar, and Joseph B. Muhlestein

Subjects
medicine.medical_specialty, Prasugrel, business.industry, Internal medicine, Conventional PCI, medicine, Cardiology, cardiovascular diseases, business, Clopidogrel, Cardiology and Cardiovascular Medicine, medicine.drug, Surgery
Published
2015
Full Text
View/download PDF

3. TCT-271 Sex-related differences in outcomes after percutaneous coronary intervention (PCI) in patients with diabetes presenting with acute coronary syndrome (ACS): Results from the PROMETHEUS study

Author

Catalin Toma, Brian A. Baker, Mark B. Effron, William S. Weintraub, Jaya Chandrasekhar, Samantha Sartori, Sunil V. Rao, Craig Strauss, Roxana Mehran, Usman Baber, J. Brent Muhlestein, Melissa Aquino, Serdar Farhan, Timothy D. Henry, Birgit Vogel, Sandra Weiss, Anthony C. DeFranco, Annapoorna Kini, Stuart Keller, Samir R. Kapadia, and Stuart J. Pocock

Subjects
Acute coronary syndrome, medicine.medical_specialty, business.industry, medicine.medical_treatment, Percutaneous coronary intervention, 030209 endocrinology & metabolism, Sex related, Disease, medicine.disease, 03 medical and health sciences, 0302 clinical medicine, Increased risk, Diabetes mellitus, Internal medicine, Conventional PCI, medicine, Cardiology, In patient, 030212 general & internal medicine, Cardiology and Cardiovascular Medicine, business
Abstract

While overall mortality in cardiovascular disease has declined, some groups such as females with diabetes are still at increased risk for worse outcome after ACS. We aimed to compare 1-year outcomes between female and male ACS patients after PCI stratified by the presence of diabetes mellitus (DM

Published
2016
Full Text
View/download PDF

4. TCT-111 Relationship between anemia, prasugrel use and clinical outcomes in contemporary percutaneous coronary intervention for acute coronary syndromes

Author

Birgit Vogel, Sandra Weiss, Timothy D. Henry, Anthony C. DeFranco, Annapoorna Kini, William S. Weintraub, Roxana Mehran, Samir R. Kapadia, Brian A. Baker, Stuart J. Pocock, Samantha Sartori, Usman Baber, Stuart Keller, Michela Faggioni, Sunil V. Rao, Craig Strauss, Jaya Chandrasekhar, J. Brent Muhlestein, Melissa Aquino, Serdar Farhan, Catalin Toma, and Mark B. Effron

Subjects
medicine.medical_specialty, Acute coronary syndrome, Prasugrel, Thienopyridine, Anemia, business.industry, medicine.medical_treatment, Percutaneous coronary intervention, 030204 cardiovascular system & hematology, medicine.disease, 03 medical and health sciences, 0302 clinical medicine, hemic and lymphatic diseases, Internal medicine, Conventional PCI, medicine, Cardiology, cardiovascular diseases, 030212 general & internal medicine, Cardiology and Cardiovascular Medicine, business, medicine.drug
Abstract

Bleeding is a risk of potent antiplatelet therapy. Anemia is associated with increased bleeding. We sought to examine the rates of prasugrel use, thienopyridine switching and clinical outcomes by presence of anemia in contemporary percutaneous coronary intervention (PCI) for acute coronary syndrome

Published
2016
Full Text
View/download PDF

5. TCT-746 Outcomes by Total Stent Length in ACS PCI with Second Generation Drug-Eluting Stents: Results from the PROMETHEUS Study

Author

William S. Weintraub, Stuart J. Pocock, Roxana Mehran, Annapoorna Kini, Timothy D. Henry, Brian A. Baker, Anthony C. DeFranco, Birgit Vogel, Catalin Toma, Clayton Snyder, Sandra Weiss, Usman Baber, Sabato Sorrentino, Samir R. Kapadia, Sunil V. Rao, Craig Strauss, Samantha Sartori, Mark B. Effron, Jaya Chandrasekhar, Stuart Keller, and Asha M. Mahajan

Subjects
Drug, medicine.medical_specialty, Clinical events, business.industry, medicine.medical_treatment, media_common.quotation_subject, Stent, Percutaneous coronary intervention, equipment and supplies, First generation, surgical procedures, operative, Internal medicine, Conventional PCI, medicine, Cardiology, In patient, cardiovascular diseases, Risk factor, Cardiology and Cardiovascular Medicine, business, media_common
Abstract

Stent length is an independent risk factor for adverse cardiovascular events after percutaneous coronary intervention (PCI) with first generation drug eluting stents (DES). We examined the associations between stent length and clinical events in patients treated with second generation DES.

Published
2017
Full Text
View/download PDF

6. TCT-171 Clinical Outcomes Using Prasugrel or Ticagrelor Based On Physician Treatment Decisions In Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Comparative Results Using Propensity Analysis Of A Payer Database

Author

Brian R. Murphy, Yajun Zhu, Beth L. Nordstrom, George W. Vetrovec, Cliff Molife, Jason C. Simeone, Stuart Keller, Mark B. Effron, Robert L. Page, Kavita V. Nair, and Patrick L. McCollam

Subjects
medicine.medical_specialty, Acute coronary syndrome, Prasugrel, business.industry, medicine.medical_treatment, Percutaneous coronary intervention, Retrospective cohort study, medicine.disease, Clopidogrel, P2Y12, Internal medicine, medicine, In patient, cardiovascular diseases, business, Intensive care medicine, Cardiology and Cardiovascular Medicine, Ticagrelor, medicine.drug
Abstract

Prasugrel and ticagrelor are potent P2Y12 ADP receptor inhibitors that have greater clinical efficacy compared with clopidogrel, but more non-CABG bleeding. There are no direct comparisons of clinical outcomes between the drugs with follow-up through 1 year. This retrospective study compared 1 year

Published
2015
Full Text
View/download PDF

7. TCT-221 Impact of prasugrel versus clopidogrel in smokers and non-smokers undergoing PCI for ACS: Results from the PROMETHEUS Study

Author

Brian A. Baker, Sunil V. Rao, Craig Strauss, Kanhaiya L. Poddar, Stuart Keller, Usman Baber, Annapoorna Kini, Jennifer Chao, Mark B. Effron, Samir R. Kapadia, Jaya Chandrasekhar, Sandra Weiss, William S. Weintraub, Roxana Mehran, Timothy D. Henry, Anthony C. DeFranco, Joseph B. Muhlestein, Melissa Aquino, and Samantha Sartori

Subjects
medicine.medical_specialty, Prasugrel, business.industry, Internal medicine, Conventional PCI, medicine, Cardiology, cardiovascular diseases, business, Clopidogrel, Cardiology and Cardiovascular Medicine, medicine.drug
Published
2015
Full Text
View/download PDF

8. MULTIVESSEL VERSUS CULPRIT-ONLY PCI IN PATIENTS WITH NON-ST SEGMENT ELEVATION MYOCARDIAL INFARCTION AND MULTIVESSEL DISEASE: RESULTS FROM THE PROMETHEUS STUDY

Author

Timothy Henry, Stuart Keller, Birgit Vogel, William S. Weintraub, Sandra Weiss, Jaya Chandrasekhar, Serdar Farhan, Stuart J. Pocock, Anthony C. DeFranco, Brian A. Baker, Samantha Sartori, Sunil V. Rao, Samir Kapadia, Catalin Toma, Sabato Sorrentino, Roxana Mehran, J. Muhlestein, Annapoorna Kini, Usman Baber, Craig Strauss, Michela Faggioni, and Mark B. Effron

Subjects
medicine.medical_specialty, business.industry, medicine.medical_treatment, Multivessel disease, medicine.disease, Revascularization, Culprit, Internal medicine, Conventional PCI, medicine, Cardiology, ST segment, Observational study, In patient, cardiovascular diseases, Myocardial infarction, Cardiology and Cardiovascular Medicine, business
Abstract

Background: Multivessel (MV) disease is present in a significant number of patients with non-ST-segment elevation myocardial infarction (NSTEMI). The optimal revascularization strategy in these patients is uncertain. Methods: PROMETHEUS was a multicenter observational study of patients undergoing

Published
2017
Full Text
View/download PDF

9. USE OF POTENT P2Y12 INHIBITORS IN AFRICAN-AMERICAN PATIENTS TREATED WITH PERCUTANEOUS CORONARY INTERVENTION FOR ACUTE CORONARY SYNDROMES

Author

Birgit Vogel, William Weintraub, Sandra Weiss, Mark B. Effron, J. Muhlestein, Stuart Keller, Brian Baker, Michela Faggioni, Clayton Snyder, Sunil Rao, Jaya Chandrasekhar, Melissa Aquino, Catalin Toma, Samantha Sartori, Stuart Pocock, Timothy D. Henry, Craig Strauss, Samir Kapadia, Roxana Mehran, Anthony DeFranco, Usman Baber, and Annapoorna Kini

Subjects
African american, medicine.medical_specialty, Acute coronary syndrome, Prasugrel, business.industry, medicine.medical_treatment, Percutaneous coronary intervention, 030204 cardiovascular system & hematology, medicine.disease, Clopidogrel, 03 medical and health sciences, 0302 clinical medicine, P2Y12, Internal medicine, Conventional PCI, Medicine, cardiovascular diseases, 030212 general & internal medicine, Cardiology and Cardiovascular Medicine, business, Cardiovascular outcomes, medicine.drug
Abstract

Background: African American (AA) patients are at high risk for adverse cardiovascular outcomes after PCI, thus providing a rationale for use of potent P2Y12 inhibitors in such individuals. However, whether or not race is a determinant of prasugrel versus clopidogrel use in acute coronary syndrome (

Published
2017
Full Text
View/download PDF

10. TCT-221 Predictors of optimal medical therapy on discharge after percutaneous coronary intervention for acute coronary syndrome: An analysis of the PROMETHEUS registry

Author

Roxana Mehran, Timothy D. Henry, Gennaro Giustino, J. Brent Muhlestein, Brian A. Baker, Usman Baber, Catalin Toma, William S. Weintraub, Stuart J. Pocock, Sandra Weiss, Stuart Keller, Sunil V. Rao, Craig Strauss, Jaya Chandrasekhar, Mark B. Effron, Samir R. Kapadia, Annapoorna Kini, Melissa Aquino, Serdar Farhan, Anthony C. DeFranco, and Samantha Sartori

Subjects
Acute coronary syndrome, medicine.medical_specialty, Pharmacotherapy, business.industry, medicine.medical_treatment, medicine, Percutaneous coronary intervention, Cardiology and Cardiovascular Medicine, medicine.disease, business, Intensive care medicine, Medical therapy
Published
2016
Full Text
View/download PDF

11. TCT-105 Prevalence of prasugrel use and associations between type of acute coronary syndrome and 1-year clinical outcomes

Author

Jaya Chandrasekhar, J. Brent Muhlestein, Catalin Toma, Asim M. Rafique, Usman Baber, William S. Weintraub, Sandra Weiss, Roxana Mehran, Stuart Keller, Brian A. Baker, Stuart J. Pocock, Mark B. Effron, Melissa Aquino, Samir R. Kapadia, Sunil V. Rao, Craig Strauss, Annapoorna Kini, Timothy D. Henry, Anthony C. DeFranco, and Samantha Sartori

Subjects
medicine.medical_specialty, Acute coronary syndrome, Prasugrel, business.industry, Internal medicine, Cardiology, Medicine, Cardiology and Cardiovascular Medicine, business, medicine.disease, medicine.drug
Published
2016
Full Text
View/download PDF

12. PREDICTORS OF 1 YEAR NET ADVERSE CARDIOVASCULAR EVENTS (NACE) AMONG ACS PATIENTS UNDERGOING PCI WITH CLOPIDOGREL OR PRASUGREL: ANALYSIS FROM THE PROMETHEUS REGISTRY

Author

Brian Baker, J. Muhlestein, Samir R. Kapadia, Siddharth A. Wayangankar, Annapoorna Kini, Catalin Toma, Timothy D. Henry, Stuart Keller, Sandra Weiss, Samantha Sartori, Anthony C. DeFranco, Roxana Mehran, Mark B. Effron, William S. Weintraub, Usman Baber, Kanhaiya L. Poddar, Sunil V. Rao, and Craig Strauss

Subjects
medicine.medical_specialty, Prasugrel, business.industry, 030204 cardiovascular system & hematology, Clopidogrel, Surgery, 03 medical and health sciences, 0302 clinical medicine, Conventional PCI, Emergency medicine, medicine, 030212 general & internal medicine, Cardiology and Cardiovascular Medicine, business, medicine.drug
Published
2016
Full Text
View/download PDF

13. USE OF CLOPIDOGREL VERSUS PRASUGREL IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: FACTORS INFLUENCING REAL-WORLD THERAPEUTIC DECISION-MAKING

Author

Samir Kapadia, Anthony C. DeFranco, Timothy Henry, Sandra Weiss, Samantha Sartori, Stuart J. Pocock, Roxana Mehran, Melissa Aquino, Annapoorna Kini, Stuart Keller, Brian A. Baker, Jaya Chandrasekhar, William S. Weintraub, Usman Baber, J. Muhlestein, Catalin Toma, Mark B. Effron, Olga Salianski, Sunil V. Rao, and Kanhaiya L. Poddar

Subjects
medicine.medical_specialty, Acute coronary syndrome, Prasugrel, business.industry, medicine.medical_treatment, Percutaneous coronary intervention, Therapeutic decision making, Platelet inhibition, Clopidogrel, medicine.disease, Internal medicine, Conventional PCI, Cardiology, Medicine, In patient, cardiovascular diseases, Cardiology and Cardiovascular Medicine, business, medicine.drug
Abstract

The determinants of clinical decision-making for potent platelet inhibition with prasugrel versus clopidogrel in real-world patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) remain poorly characterized. The purpose of this study was to identify factors

Published
2016
Full Text
View/download PDF

14. INCIDENCE, PREDICTORS AND IMPACT OF STROKE AFTER PERCUTANEOUS CORONARY INTERVENTION FOR ACUTE CORONARY SYNDROMES: RESULTS FROM THE PROMETHEUS REGISTRY

Author

Stuart J. Pocock, Kanhaiya L. Poddar, Samantha Sartori, Usman Baber, Mark B. Effron, Samir Kapadia, Gennaro Giustino, J. Muhlestein, Timothy Henry, Brian A. Baker, Stuart Keller, Melissa Aquino, Sandra Weiss, Roxana Mehran, Jaya Chandrasekhar, Catalin Toma, Sunil V. Rao, Shunsuke Aoi, Anthony C. DeFranco, and William S. Weintraub

Subjects
medicine.medical_specialty, business.industry, Incidence (epidemiology), medicine.medical_treatment, Conventional PCI, medicine, Percutaneous coronary intervention, cardiovascular diseases, Cardiology and Cardiovascular Medicine, Intensive care medicine, medicine.disease, business, Stroke
Abstract

The contemporary incidence, associated factors and implications of stroke after acute coronary syndromes (ACS) managed with percutaneous coronary intervention (PCI) and novel antiplatelet drugs is unknown. We sought to characterize the incidence, predictors and impact of stroke on subsequent

Published
2016
Full Text
View/download PDF

15. TCT-219 Impact of prasugrel versus clopidogrel in ACS patients undergoing PCI with short or long stents: Results from the PROMETHEUS Study

Author

Annapoorna Kini, Kanhaiya L. Poddar, Samantha Sartori, Melissa Aquino, William S. Weintraub, Brian A. Baker, Mark B. Effron, Timothy D. Henry, Usman Baber, Sandra Weiss, Anthony C. DeFranco, Joseph B. Muhlestein, Stuart Keller, Roxana Mehran, Jennifer Chao, Samir R. Kapadia, Jaya Chandrasekhar, Sunil V. Rao, and Craig Strauss

Subjects
medicine.medical_specialty, Prasugrel, animal structures, business.industry, medicine.medical_treatment, Percutaneous coronary intervention, Stent, Revascularization, Clopidogrel, surgical procedures, operative, Internal medicine, Conventional PCI, medicine, Cardiology, cardiovascular diseases, Adverse effect, business, Cardiology and Cardiovascular Medicine, medicine.drug
Abstract

Randomized data have shown that prasugrel is superior to clopidogrel in reducing ischemic risk including unplanned revascularization, albeit with increased bleeding. Greater stent length is also an independent correlate of adverse events after percutaneous coronary intervention (PCI). We sought to

Full Text
View/download PDF

16. TCT-487 Temporal Associations Between Myocardial Infarction, Major Bleeding and Mortality Risk in ACS Patients Undergoing PCI: Insights from the PROMETHEUS Cohort

Author

Roxana Mehran, William S. Weintraub, Stuart J. Pocock, Jennifer Chao, Jaya Chandrasekhar, Samir R. Kapadia, Mark B. Effron, Joseph B. Muhlestein, Catalin Toma, Stuart Keller, Usman Baber, Melissa Aquino, Sunil V. Rao, Craig Strauss, Sandra Weiss, Brian A. Baker, Annapoorna Kini, Samantha Sartori, Timothy D. Henry, and Anthony C. DeFranco

Subjects
medicine.medical_specialty, business.industry, medicine.disease, surgical procedures, operative, Emergency medicine, Conventional PCI, Cohort, medicine, Myocardial infarction, cardiovascular diseases, Cardiology and Cardiovascular Medicine, Intensive care medicine, business, Major bleeding
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results